Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
VaxAid erection ring 32mm - 40mm
21180000118
|
VaxAid erection ring 32mm - 40mm | Erectile Dysfunction Devices | Appliances | No data available |
|
VaxAid erection ring 36mm
21180000114
|
VaxAid erection ring 36mm | Erectile Dysfunction Devices | Appliances | No data available |
|
VaxAid erection ring 40mm
21180000115
|
VaxAid erection ring 40mm | Erectile Dysfunction Devices | Appliances | No data available |
|
Vaxalin XL 150mg capsules
0403040W0BKABAE
|
Vaxalin | Venlafaxine | Central Nervous System | No data available |
|
Vaxalin XL 75mg capsules
0403040W0BKAAAD
|
Vaxalin | Venlafaxine | Central Nervous System | No data available |
|
Vaxigrip Trivalent Flu/Vac/Split inj 0.5ml pfs
1404000H0CGAAAU
|
Vaxigrip | Influenza | Immunological Products and Vaccines | No data available |
|
Vaxneuvance vacc inj 0.5ml pre-filled syringes
1404000L0BHAAAF
|
Vaxneuvance | Pneumococcal | Immunological Products and Vaccines | No data available |
|
Vecicom 100mg prolonged-release tablets
0407020AGBFABAD
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 150mg prolonged-release tablets
0407020AGBFACAE
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 200mg prolonged-release tablets
0407020AGBFADAF
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 250mg prolonged-release tablets
0407020AGBFAEAG
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 50mg prolonged-release tablets
0407020AGBFAAAC
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vectavir Cold Sore 1% cream
1310030L0BBAAAA
|
Vectavir | Penciclovir | Skin | No data available |
|
Vectibix 100mg/5ml concentrate for inf vials
0801050ARBBAAAA
|
Vectibix | Panitumumab | Malignant Disease and Immunosuppression | No data available |
|
Vectibix 400mg/20ml concentrate for inf vials
0801050ARBBABAB
|
Vectibix | Panitumumab | Malignant Disease and Immunosuppression | No data available |
|
Vecuronium bromide 10mg powder for soln inj vials
1501050V0AAABAB
|
Vecuronium bromide | Vecuronium bromide | Anaesthesia | No data available |
|
Vecuronium bromide poder and solvent 10mg inj vials
1501050V0AAAAAA
|
Vecuronium bromide | Vecuronium bromide | Anaesthesia | No data available |
|
VED Axis constrictor ring size 4
21180000119
|
VED Axis constrictor ring size 4 | Erectile Dysfunction Devices | Appliances | No data available |
|
VED Axis constrictor ring size 6
21180000120
|
VED Axis constrictor ring size 6 | Erectile Dysfunction Devices | Appliances | No data available |
|
VED Axis Firma Band
21180000121
|
VED Axis Firma Band | Erectile Dysfunction Devices | Appliances | No data available |
|
VED Axis Sensation Seal size 2
21180000122
|
VED Axis Sensation Seal size 2 | Erectile Dysfunction Devices | Appliances | No data available |
|
VED Axis Sensation Seal size 3
21180000123
|
VED Axis Sensation Seal size 3 | Erectile Dysfunction Devices | Appliances | No data available |
|
Vedolizumab 108mg/.068ml inj pre-filled disposable devices
0105030A0AAACAC
|
Vedolizumab | Vedolizumab | Gastro-Intestinal System | No data available |
|
Vedolizumab 108mg/0.68ml inj pre-filled syringes
0105030A0AAABAB
|
Vedolizumab | Vedolizumab | Gastro-Intestinal System | No data available |
|
Vedolizumab 300mg powder for solution for infusion vials
0105030A0AAAAAA
|
Vedolizumab | Vedolizumab | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.